Premier Fund Managers’s Castle Biosciences CSTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-14,783
| Closed | -$312K | – | 192 |
|
|
2024
Q2 | $312K | Hold |
14,783
| – | – | 0.01% | 177 |
|
|
2024
Q1 | $314K | Buy |
+14,783
| New | +$314K | 0.01% | 186 |
|
|
2023
Q1 | – | Sell |
-38,502
| Closed | -$892K | – | 227 |
|
|
2022
Q4 | $892K | Sell |
38,502
-13,780
| -26% | -$319K | 0.03% | 178 |
|
|
2022
Q3 | $1.33M | Hold |
52,282
| – | – | 0.1% | 98 |
|
|
2022
Q2 | $1.2M | Hold |
52,282
| – | – | 0.05% | 162 |
|
|
2022
Q1 | $2.3M | Hold |
52,282
| – | – | 0.08% | 153 |
|
|
2021
Q4 | $2.29M | Sell |
52,282
-29,772
| -36% | -$1.31M | 0.07% | 148 |
|
|
2021
Q3 | $5.32M | Hold |
82,054
| – | – | 0.17% | 131 |
|
|
2021
Q2 | $6.12M | Sell |
82,054
-26,387
| -24% | -$1.97M | 0.21% | 118 |
|
|
2021
Q1 | $6.76M | Hold |
108,441
| – | – | 0.26% | 100 |
|
|
2020
Q4 | $7.46M | Buy |
108,441
+35,996
| +50% | +$2.48M | 0.32% | 72 |
|
|
2020
Q3 | $3.66M | Buy |
+72,445
| New | +$3.66M | 0.21% | 111 |
|